Mexico Adds 28,115 Covid Cases in Change to Counting Strategy
(Bloomberg) -- Mexico posted a record 28,115 Covid-19 cases Monday in what the government says is a change to its counting strategy.
Deaths also rose by a record 2,789 to a total of 81,877, health authorities said at the daily evening presser to update on the coronavirus outbreak. Both new cases and deaths didn't necessarily occur in the past 24 hours, they said, but are just now being added to the count due to lags in recording.
Mexico will now take into account “epidemiological association” in its tally of cases and deaths, said Health Ministry epidemiology director Jose Luis Alomia. That means adding suspicious cases and deaths among those in direct contact with a confirmed case but did not receive a test. Mexico's reduced testing, which has led to one of the world's highest positivity rates at 41%, has been widely criticized by medical experts.
Last week, Alomia said the country had lost 93,803 tests for various reasons.
Excess deaths in Mexico have reached 173,578 through Aug. 31, news website Animal Politico reported Sunday evening. The count includes people who died from causes unrelated to the virus but could or would not get medical care due to the pandemic.
©2020 Bloomberg L.P.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.